Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis

[1]  A. Saraya,et al.  Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis , 2014, BMC Cancer.

[2]  J. Ferlay,et al.  Global estimates of cancer prevalence for 27 sites in the adult population in 2008 , 2013, International journal of cancer.

[3]  R. Pietrobon,et al.  Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. , 2012, Journal of the American College of Surgeons.

[4]  G. Jiang,et al.  Long-term outcome of irradiation with or without chemotherapy for esophageal squamous cell carcinoma: a final report on a prospective trial , 2012, Radiation oncology.

[5]  J. Reynolds,et al.  Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. , 2011, Cancer epidemiology.

[6]  J. Wands,et al.  Role of Rac1 in regulation of NOX5-S function in Barrett's esophageal adenocarcinoma cells. , 2011, American journal of physiology. Cell physiology.

[7]  B. Greenwald,et al.  Cryotherapy for Barrett's esophagus and esophageal cancer , 2011, Current opinion in gastroenterology.

[8]  Yung‐Chie Lee,et al.  Genetic Variants in DNA Repair Predicts the Survival of Patients with Esophageal Cancer , 2011, Annals of surgery.

[9]  N. Gusani,et al.  Multidisciplinary Management of Early and Locally Advanced Esophageal Cancer , 2011, Journal of clinical gastroenterology.

[10]  D. Low.  Update on Staging and Surgical Treatment Options for Esophageal Cancer , 2011, Journal of Gastrointestinal Surgery.

[11]  D. Cunningham,et al.  Optimal Therapeutic Strategies for Resectable Oesophageal or Oesophagogastric Junction Cancer , 2011, Drugs.

[12]  Yung‐Chie Lee,et al.  Polymorphism in Epidermal Growth Factor Receptor Intron 1 Predicts Prognosis of Patients with Esophageal Cancer after Chemoradiation and Surgery , 2011, Annals of Surgical Oncology.

[13]  A. Saraya,et al.  Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma , 2011, Cancer investigation.

[14]  J. Grigull,et al.  Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer , 2010, PloS one.

[15]  M. Canto,et al.  Predicting Neoplastic Progression in Barrett's Esophagus. , 2010, Annals of gastroenterology & hepatology.

[16]  R. Bast,et al.  MEKK3 expression correlates with nuclear factor κ B activity and with expression of antiapoptotic genes in serous ovarian carcinoma , 2009, Cancer.

[17]  Rinu Sharma,et al.  Clinical significance of 14-3-3 zeta in human esophageal cancer. , 2008, The International journal of biological markers.

[18]  B. Su,et al.  MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis. , 2007, American journal of physiology. Cell physiology.

[19]  R. Ralhan,et al.  Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray , 2007, International journal of cancer.

[20]  M. Karin,et al.  Mitogen-activated protein kinase cascades and regulation of gene expression. , 1996, Current opinion in immunology.

[21]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[22]  Mingxin Zhang,et al.  Role of cancer-related inflammation in esophageal cancer. , 2013, Critical reviews in eukaryotic gene expression.

[23]  R. Pietrobon,et al.  Is radiation without surgery the adequate therapy for potentially resectable esophageal squamous cell carcinoma? An analysis using the Surveillance Epidemiology, and End Results registry from 1998 to 2008 , 2012 .

[24]  PhD J. J. B. van Lanschot MD,et al.  FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review , 2011, Annals of Surgical Oncology.

[25]  S. Ghanny,et al.  iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. , 2009, Journal of proteome research.

[26]  M. Campo,et al.  HPV and oesophageal carcinoma. , 2006 .

[27]  V. Gajalakshmi,et al.  An Independent Survey to Assess Completeness of Registration: Population Based Cancer Registry, Chennai, India. , 2001, Asian Pacific journal of cancer prevention : APJCP.

[28]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[29]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[30]  S. Franceschi,et al.  EPIDEMIOLOGY OF ESOPHAGEAL CANCER , 2013 .